Pfizer To Acquire Obesity-Drug Maker Metsera For $4.9bn
US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday.
With the purchase, Pfizer aims to expand its portfolio by entering the huge and growing…